# Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer

> **NCT00098995** · PHASE1 · COMPLETED · sponsor: **Peter MacCallum Cancer Centre, Australia** · enrollment: 22 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** tirapazamine
- **RADIATION:** brachytherapy
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00098995
- **Lead sponsor:** Peter MacCallum Cancer Centre, Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2013-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00098995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00098995, "Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00098995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*